JAMA · 1984 · 20 citations · 5 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyHypertension ManagementPsychotic DisordersSchizophrenia PharmacotherapyAcute Exacerbation TreatmentAntipsychotic ActionAntipsychotic EfficacyCardiopulmonary ArrestCardiopulmonary ComplicationsHaloperidol PharmacologyLow-sodium DietPropranolol Therapy
HALOPERIDOL exerts its antipsychotic effect presumably through potent blockade of central dopamine receptors<sup>1</sup>and has caused hypotension in some patients.<sup>2</sup>Propranolol hydrochloride is a β-adrenergic receptor blocking drug that is widely used in treating hypertension. A review of the literature does not disclose adverse effects in patients from a combination of haloperidol and propranolol. We report herein a patient who had three episodes of hypotension and two episodes of cardiopulmonary arrest after taking concurrent oral doses of haloperidol and propranolol. <h3>Report of a Case</h3> A 48-year-old white woman with a 27-year history of schizophrenia was first admitted to our hospital in 1980. At that time, the patient was treated with haloperidol, 20 mg/day, for an acute exacerbation of her illness. Her symptoms resolved rapidly. The patient was also noted to have hypertension and was treated with a low-sodium diet and with trichlormethiazide, 4 mg/day, which controlled her hypertension. In
5
Relaxation by dopaminergic agonists in cerebral and peripheral arteries (in vitro).
Nicole Oudart, R. Sercombe, P. Aubineau et al. · PubMed · 1981 · 16 citations
Medicine, Neurobiology, Pharmacology +14
Daphné Atlas, Zeev Friedman, Y Litvin et al. · British Journal of Pharmacology · 1982 · 11 citations · Full text